Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

PARICALCITOL

PARICALCITOL

Standard Dose
2MCG/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: None (Tentative Approval)
Summary

Approval overview PARICALCITOL is listed in Drugs@FDA under application 091583 (ANDA).

Marketing status: None (Tentative Approval) Active ingredient PARICALCITOL Form and strength INJECTABLE; INJECTION - 2MCG/ML Sponsor TEVA PHARMS USA Submission history Latest submission status date: 2013-11-05 00:00:00.

Structured Monograph

Clinical summary

Approval overview PARICALCITOL is listed in Drugs@FDA under application 091583 (ANDA). Marketing status: None (Tentative Approval) Active ingredient PARICALCITOL Form and strength INJECTABLE; INJECTION - 2MCG/ML Sponsor TEVA PHARMS USA Submission history Latest submission status date: 2013-11-05 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: None (Tentative Approval)

Interaction Notes

  • No interaction notes stored yet.